COMMUNIQUÉS West-GlobeNewswire

Arcturus Therapeutics Achieves Program Milestones and Refines Agreement with Cystic Fibrosis Foundation Therapeutics
23/07/2018
SAN DIEGO, July 23, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced the achievement of key milestones as part of its agreement with Cystic Fibrosis [...]
Epizyme Appoints Dr. Shefali Agarwal as Chief Medical Officer
23/07/2018
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage company developing novel epigenetic therapies, today announced the appointment of Dr. Shefali Agarwal as chief medical [...]
Agios to Webcast Conference Call of Second Quarter 2018 Financial Results on August 2, 2018
23/07/2018
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]
Intra-Cellular Therapies Announces Publication Highlighting ITI-214 Mechanism of Action and Describing Positive Results in Preclinical Models of Heart Failure
23/07/2018
Data indicates ITI-214 acts by a novel mechanism of action via modulation of the adenosine A 2B receptor signaling pathway ITI-214 increases cardiac contractility without increasing intracellular calcium These data may [...]
Auxly Announces Issuance of Sales Licence for Kolab Project and Provides Update on Saskatchewan Retail Strategy
23/07/2018
VANCOUVER, British Columbia, July 23, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") is pleased to announce that its wholly-owned subsidiary, Kolab Project Inc. (" Kolab " [...]
Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in CKD Caused by Alport Syndrome and Autosomal Dominant Polycystic Kidney Disease
23/07/2018
Statistically Significant Improvement in Kidney Function Maintained in Alport Syndrome Patients After 48 Weeks of Treatment Statistically Significant Retained Benefit of 4.1 mL/min in Alport Syndrome Patients Following [...]
Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network
23/07/2018
-- Conference Call at 8:30 a.m. ET Today -- EAST RUTHERFORD, N.J., July 23, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical [...]
HEXO Reaches Major Milestone in Ongoing Expansion Plans
23/07/2018
GATINEAU, Quebec, July 23, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) has reached a major milestone in its expansion plans, designed to position HEXO as one of the [...]
HEXO franchit une étape importante dans ses plans d'expansion en cours
23/07/2018
GATINEAU, Québec, 23 juill. 2018 (GLOBE NEWSWIRE) -- La Société Hydropothecary (« HEXO » ou « la Société ») (TSX:HEXO) a franchi une étape importante dans ses plans d'expansion visant à positionner HEXO comme l'un des [...]
Sernova Completes Oversubscribed Private Placement of $2,754,000
23/07/2018
LONDON, Ontario, July 23, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces it has completed a non-brokered private placement of $2.754 million, pursuant to which Sernova issued a [...]
PotNetwork Holding's Diamond CBD Scores Over $300,000 in Sales at the 38th Las Vegas CHAMPS Show
23/07/2018
The Company Continues Record Breaking Trend, Having Showcased Growing Product line to Vendors at the World’s Most Trusted Counter-Culture Trade Show FT LAUDERDALE, Fla., July 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE [...]
Transactions under Novozymes’ stock buyback program
23/07/2018
Please read the full announcement in the attached PDF Attachment 2018_44_Stock_Buybackprogram_EN
Novo Nordisk A/S: Share repurchase programme
23/07/2018
Bagsværd, Denmark, 23 July 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Immunicum AB (publ) Announces Protocol Approval by the FDA Enabling the Initiation of Expanded Multi-indication Phase Ib/II Combination Trial
23/07/2018
Press Release 23 July 2018 Immunicum AB (publ) Announces Protocol Approval by the FDA Enabling the Initiation of Expanded Multi-indication Phase Ib/II Combination Trial Immunicum AB (publ; IMMU.ST) announced today that [...]
Shire plc : Notice of Results
23/07/2018
Shire to announce second quarter 2018 results Dublin, Ireland - July 23, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce second quarter 2018 earnings on Tuesday July 31, 2018. Results press release will be [...]
Chi-Med Initiates a Phase Ib/II Proof-of-Concept Trial of Sulfatinib in Pancreatic Neuroendocrine Tumors and Biliary Tract Cancer in the United States
23/07/2018
LONDON, July 23, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM:HCM) (Nasdaq:HCM) has initiated a Phase Ib/II proof-of-concept study of sulfatinib in pancreatic neuroendocrine tumors (“NET [...]
Novartis renews drug donation of Egaten® (triclabendazole) until 2022, reaffirming its commitment to the fight against liver fluke
23/07/2018
Novartis extends agreement with the WHO for the donation of Egaten ® for the treatment of liver fluke, a neglected tropical disease, also known as fascioliasis, that infects more than 2.4 million people globally[1] [...]
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
23/07/2018
NEWS RELEASE Providing Nationwide Coverage for Medicare Patients IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 23, 2018 - MDxHealth SA (Euronext: MDXH.BR), today announced that Palmetto GBA, a Medicare [...]
MDxHealth (R) :
23/07/2018

Pages